<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Post-transplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) constitutes a serious complication of allogeneic bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a case of PTLD in a twenty-six year-old male treated with bone marrow transplantation for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> of unknown cause </plain></SENT>
<SENT sid="2" pm="."><plain>The patient received unmanipulated marrow graft from his HLA-matched brother </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty-one days post transplant he developed progressive enlargement of cervical lymph nodes, followed by <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo> and <z:hpo ids='HP_0008940'>generalized lymphadenopathy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1301361" disease_type="Neoplastic Process" abbrv="">Polymorphic PTLD</z:e> was diagnosed basing on the lymph node histopathology, positive EBV detection, flow cytometry and IgH rearrangement studies proving monoclonality (capillary electrophoresis with ABI PRISM 310 Genetic Analyzer) </plain></SENT>
<SENT sid="5" pm="."><plain>There was no response to anti-CD20 antibody, cessation of immunosuppression, donor lymphocyte infusion and <z:chebi fb="0" ids="35610">cytostatic</z:chebi> therapy </plain></SENT>
<SENT sid="6" pm="."><plain>The patient died on the 65th day of multiple organ failure </plain></SENT>
<SENT sid="7" pm="."><plain>We discuss the diagnostics and management of PTLD in the setting of bone marrow transplantation </plain></SENT>
</text></document>